Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations
Received 8 April 2020
Accepted for publication 30 May 2020
Published 29 July 2020 Volume 2020:15 Pages 5389—5403
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Editor who approved publication: Prof. Dr. Thomas J. Webster
Yue Zhang,1 Rui Zhang,1 Upulitha Eranka Illangakoon,1,2 Anthony Henry Harker,3 Christopher Thrasivoulou,4 Maryam Parhizkar,1,2 Mohan Edirisinghe,1 CJ Luo1
1Department of Mechanical Engineering, University College London, London WC1E 7JE, UK; 2UCL School of Pharmacy, University College London, London WC1N 1AX, UK; 3Department of Physics & Astronomy, University College London, London WC1E 6BT, UK; 4Cell & Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK
Correspondence: CJ Luo Tel +44 20 7679 3942
Hypothesis: Developing oral formulations to enable effective release of poorly water-soluble drugs like progesterone is a major challenge in pharmaceutics. Coaxial electrospray can generate drug-loaded nanoparticles of strategic compositions and configurations to enhance physiological dissolution and bioavailability of poorly water-soluble drug progesterone.
Experiments: Six formulations comprising nanoparticles encapsulating progesterone in different poly(lactide-co-glycolide) (PLGA) matrix configurations and compositions were fabricated and characterized in terms of morphology, molecular crystallinity, drug encapsulation efficiency and release behavior.
Findings: A protocol of fabrication conditions to achieve 100% drug encapsulation efficiency in nanoparticles was developed. Scanning electron microscopy shows smooth and spherical morphology of 472.1± 54.8 to 588.0± 92.1 nm in diameter. Multiphoton Airyscan super-resolution confocal microscopy revealed core-shell nanoparticle configuration. Fourier transform infrared spectroscopy confirmed presence of PLGA and progesterone in all formulations. Diffractometry indicated amorphous state of the encapsulated drug. UV-vis spectroscopy showed drug release increased with hydrophilic copolymer glycolide ratio while core-shell formulations with progesterone co-dissolved in PLGA core exhibited enhanced release over five hours at 79.9± 1.4% and 70.7± 3.5% for LA:GA 50:50 and 75:25 in comparison with pure progesterone without polymer matrix in the core at 67.0± 1.7% and 57.5± 2.8%, respectively. Computational modeling showed good agreement with the experimental drug release behavior in vitro.
Keywords: core-shell nanoparticles, oral formulations, bioavailability, drug delivery, poorly water-soluble drugs, progesterone, poly, lactide-co-glycolide, PLGA, copolymer, coaxial electrospray
This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Download Article [PDF] View Full Text [HTML][Machine readable]